Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Changes of influenza vaccination rate and associated influencing factors after the COVID-19 pandemic in Shanghai, ChinaHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2287294-2287294 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2287294 ;PMID: 38299510Full text available |
|
2 |
Material Type: Article
|
Sexual and preventive behaviors associated with HAV, HBV, and HPV vaccine hesitancy among men who have sex with men in FranceHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2348845-2348845 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2348845 ;PMID: 38783608Full text available |
|
3 |
Material Type: Article
|
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from NigeriaHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2355036-2355036 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2355036 ;PMID: 38783606Full text available |
|
4 |
Material Type: Article
|
Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and TanzaniaGlobal health action, 2024-12, Vol.17 (1), p.2345970-2345970 [Peer Reviewed Journal]EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2345970 ;PMID: 38774927Full text available |
|
5 |
Material Type: Article
|
Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic reviewHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341456-2341456 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2341456 ;PMID: 38650460Full text available |
|
6 |
Material Type: Article
|
Human papillomavirus and occupational exposure: The need for vaccine provision for healthcare providersHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2342622-2342622 [Peer Reviewed Journal]2024 Mayo Foundation for Medical Education and Research. Published with license by Taylor & Francis Group, LLC. 2024 Mayo Foundation for Medical Education and Research ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2342622 ;PMID: 38771122Full text available |
|
7 |
Material Type: Article
|
Number of tetanus toxoid injections before birth and associated factors among pregnant women in low and middle income countries: Negative binomial poisson regressionHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2352905-2352905 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2352905 ;PMID: 38772729Full text available |
|
8 |
Material Type: Article
|
Parental intention on getting children COVID-19 vaccinations: Invariance evaluation across parenting roles and COVID-19-like symptoms experiences among Iranians during the pandemic periodHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2325230-2325230 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;ISSN: 2164-554X ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2325230 ;PMID: 38445561Full text available |
|
9 |
Material Type: Article
|
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2304974-2304974 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2304974 ;PMID: 38512394Full text available |
|
10 |
Material Type: Article
|
Knowledge about, attitudes toward and acceptance and predictors of intention to receive the mpox vaccine among cancer patients in China: A cross-sectional surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2337157-2337157 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2337157 ;PMID: 38644633Full text available |
|
11 |
Material Type: Article
|
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteersHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2301631-2301631 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2301631 ;PMID: 38189360Full text available |
|
12 |
Material Type: Article
|
Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysisHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341454-2341454 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2341454 ;PMID: 38695296Full text available |
|
13 |
Material Type: Article
|
Opportunities for HPV vaccine education in school-based immunization programs in British Columbia, Canada: A qualitative studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2326779-2326779 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2326779 ;PMID: 38517252Full text available |
|
14 |
Material Type: Article
|
The contextual awareness, response and evaluation (CARE) diabetes project: study design for a quantitative survey of diabetes prevalence and non-communicable disease risk in Ga Mashie, Accra, GhanaGlobal health action, 2024-12, Vol.17 (1), p.2297513-2297513 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2023.2297513 ;PMID: 38323339Full text available |
|
15 |
Material Type: Article
|
No evidence, no problem? A critical interpretive synthesis of the vulnerabilities to and experiences of sexual violence among young migrants in EuropeGlobal health action, 2024-12, Vol.17 (1), p.2340114-2340114 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2340114 ;PMID: 38651216Full text available |
|
16 |
Material Type: Article
|
Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patientsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2317595-2317595 [Peer Reviewed Journal]2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2317595 ;PMID: 38502342Full text available |
|
17 |
Material Type: Article
|
Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from LibyaLibyan journal of medicine, 2024-12, Vol.19 (1), p.2356906-2356906 [Peer Reviewed Journal]ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2356906 ;PMID: 38785139Full text available |
|
18 |
Material Type: Article
|
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350091-2350091 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350091 ;PMID: 38757631Full text available |
|
19 |
Material Type: Article
|
Nonstructural barriers to adult vaccinationHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2334475-2334475 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2334475 ;PMID: 38629573Full text available |
|
20 |
Material Type: Article
|
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia PacificHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344983-2344983 [Peer Reviewed Journal]2024 GlaxoSmithKline Biologicals SA. Published with license by Taylor & Francis Group, LLC. 2024 GlaxoSmithKline ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2344983 ;PMID: 38767209Full text available |